Clinical Trials Sponsored by Urologix

Total 153 results

Axolotl Biologix

Terminated

Evaluating Intra-articular Injection of Axolotl Ambient Compared to Saline in Subjects With Ankle Osteoarthritis (Phoenix)

Ankle Osteoarthritis

United States
Neurologix, Inc.

Terminated

Study of AAV-GAD Gene Transfer Into the Subthalamic Nucleus for Parkinson's Disease

Parkinson's Disease

United States
Club Italiano Femminile di Urologia
Società Italiana di Urologia (SIU)

Unknown

Linguistic and Cultural Validation in Italian of Female Sexual Function Index (FSFI) Questionnaire

Sexual Dysfunction

Italy
Nuralogix Corporation

Recruiting

Pulse Rate and Breathing Rate Accuracy

Pulse Rate and Breathing Rate

United States
Neurologix, Inc.

Terminated

Long Term Follow-Up Study for rAAV-GAD Treated Subjects

Parkinson's Disease

United States
Acologix, Inc.

Unknown

A Randomized-Withdrawal Phase 3 Study Evaluating the Safety and Efficacy of Oral Nalfurafine HCl (AC-820)in Subjects on Hemodialysis With Uremic Pruritus (Renal Itch) (AC120-8231)

Uremic Pruritus
Acologix, Inc.

Unknown

An Observational Study of Pruritus Amongst Hemodialysis Patients (ITCH Registry)

Hemodialysis | Kidney Failure, Chronic | Chronic Disease | Pruritus

United States
Association of Urologic Oncology (AUO)

Unknown

Prospective Study to Compare a Limited Versus Extended Pelvic Lymphadenectomy During Prostatectomy (SEAL)

Prostate Cancer

Germany
Instituto de Urologia e Nefrologia

Unknown

Effects of Everolimus in Left Ventricular Hypertrophy After Conversion From Azathioprine: A Pilot Study

Left Ventricular Hypertrophy

Brazil
Urologic Consultants of Southeastern PA

Unknown

A Study to Determine the Improvement of the Symptoms of Benign Prostatic Hyperplasia (BPH) When Switching Subjects From Proscar to Avodart

Benign Prostatic Hyperplasia

United States
Urología Costa Rica

Completed

Efficacy of Rezum® in Reducing Prostate Volume

Benign Hyperplasia of Prostate

Costa Rica
Association of Urologic Oncology (AUO)

Terminated

Evaluation of Four Treatment Modalities in Prostate Cancer With Low or "Early Intermediate" Risk (PREFERE)

Prostate Cancer

Germany
Sanofi
Canadian Urologic Oncology Group

Completed

Docetaxel in Hormone Refractory Prostate Cancer (HRPC)[Weekly or 3weekly TAX + Prednisone in HRPC]

Prostatic Neoplasms
Azienda Ospedaliero-Universitaria Careggi
Società Italiana di Urologia (SIU); Italian Group for Advanced Laparo-Endoscopic...

Recruiting

International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors (i-RECORd)

Kidney Cancer

Italy, United States, Spain, United Kingdom, Belgium, Austria, Brazil, Greece, Japan, Netherlands, Poland, Russian Federation, Singapore
Danisco
Reprocell Inc; Serologix

Completed

Isolation and Characterization of Multiple Microbial Species From Diverse Healthy Adults (IsoMic)

Human Microbiome

United States
Urology of Virginia

Completed

Liposomal Bupivacaine To Control Post-Operative Pain Following BMG

Urethral Stricture

United States
Novartis
Società Italiana di Urologia (SIU)

Completed

Zoledronic Acid in the Prevention of Skeletal-related Events in Hormone Refractory and Hormone-sensitive Prostate Cancer Patients With Bone Metastases

Prostate Cancer

Italy
Melissa Marchand

Completed

Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of Mild to Moderate ED (PMD-MSC-ED-01)

Erectile Dysfunction

United States
Groupe de Recherche Clinique en Neuro-Urologie

Completed

Urethral Sensory Profile: a New Technique to Evaluate Urethral Sensation Prospective Evaluation in Patients With or Without Neurological Disorders

Urethral Cyst

France
Melissa Marchand

Completed

Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of PD (PMD-MSC-PD-01)

Peyronie's Disease

United States
Seattle Urology Research Center

Unknown

Evaluation of Solifenacin in the Treatment of OAB Symptoms in Patients Who Have Successfully Undergone GreenLight Photoselective Vaporization of the Prostate (PVP)

Nocturia | Urinary Urgency | Urinary Frequency

United States
ProstaPlant Urology System Ltd.

Unknown

Evaluation of the ProstaPlant Prostate Stent Insertion in Ex Vivo Human Prostate

Benign Prostatic Hyperplasia

Israel
Urology of Virginia
GlaxoSmithKline

Unknown

Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

United States
Myriad Genetic Laboratories, Inc.
Carolina Urologic Research Center

Completed

A Registry for Hereditary Cancer Risk Assessment and Genetic Testing

Prostate Cancer

United States
GenomeDx Biosciences Corp
Society of Urologic Oncology (SUO)

Completed

Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery (PRO-IMPACT)

Prostate Cancer

United States
Association of Urologic Oncology (AUO)
University Hospital, Essen

Unknown

Resection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT) (SMAT)

Renal Cell Carcinoma | Pulmonary Metastases

Germany
Association of Urologic Oncology (AUO)
University Hospital, Essen

Terminated

Sorafenib in Urothelium Cancer of Bladder

Bladder Cancer
Canadian Urology Research Consortium
AstraZeneca

Completed

Open Label,Phase II Trial of MAB Dose Escalation OF Bicalutamide For Biochemical Failure In Prostate Cancer Patients. (CHICS)

Prostate Cancer

Canada
MARIO ABBUD FILHO

Unknown

Effects of the Use of "de Novo" Everolimus in Renal Tranplant Population

Delayed Function of Renal Transplant

Brazil
Groupe de recherche en Urologie de la Mauricie

Unknown

Pedometer and Exercise Study in Prostate Cancer Patients With Hormonal Therapy

Prostate Cancer

Canada
University of British Columbia
Canadian Urologic Oncology Group

Completed

Lymph Node Processing Protocol for Radical Cystectomy and Pelvic Lymph Node Dissection in Bladder Cancer

Transitional Cell Carcinoma | Bladder Cancer

Canada
Angle plc
MidLantic Urology, LLC

Terminated

Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® System (CHARTER)

Prostate Cancer | Castration-resistant Prostate Cancer | Biochemically Recurrent Prostate Carcinoma | High Risk Prostate Carcinoma

United States
Canadian Urology Research Consortium
GlaxoSmithKline

Completed

Comparing 0.5 mg Dutasteride vs Placebo Daily in Men Receiving Androgen Ablation Therapy for Prostate Cancer (AVIAS)

Prostate Cancer

Canada
Urology of Virginia
Ferring Pharmaceuticals

Completed

Initiation of Androgen Deprivation Therapy for Prostate Cancer Using Degarelix Followed by Leuprolide

Prostate Cancer

United States
St. Luke's Medical Center, Philippines
Philippine Board of Urology; Philippine Urology Residents Association

Completed

2013 Annual National Digital Rectal Exam (DRE) Day Study

Benign Prostatic Hyperplasia | Prostate Cancer | Prostatitis

Philippines
Duke University
University of California, Los Angeles; VA Greater Los Angeles Healthcare System and other collaborators

Terminated

Atkins Diet and Prostate Cancer Clinical Trial

Prostate Cancer

United States
MidLantic Urology
Blue Earth Diagnostics

Not yet recruiting

Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management

Prostate Cancer

United States
AmPurity Nutraceuticals, LLC
Arkansas Urology

Not yet recruiting

Nutritional Supplementation for Recurrent Urinary Tract Infections in Women

Recurrent Urinary Tract Infection
Namida Lab
Arkansas Urology; CARTI

Enrolling by invitation

Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study

Melanoma | Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer

United States
Mutah University
Istishari Urology Center

Completed

Detrusor Underactivity: Presentation and Urodynamic Characteristics

Detrusor Underactivity

Jordan
Institute of Nephro Urology, Bangalore

Completed

Efficacy of Preprocedural Diclofenac in Males Undergoing Double J Stent Removal Under Local Anesthesia

Pain

India
Chesapeake Urology Research Associates
Sanofi

Completed

An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract Symptoms

Lower Urinary Tract Symptoms | Erectile Dysfunction

United States
Canadian Urology Research Consortium
Bayer

Withdrawn

Radium 223 Following Intermittent ADT (RAND)

Prostate Cancer

Canada
Southern China Urology Cancer Consortium

Unknown

Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC Patients

Carcinoma, Renal Cell | Self Efficacy | Adverse Drug Event

China
Association of Urologic Oncology (AUO)
Eli Lilly and Company

Unknown

Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer

Carcinoma, Transitional Cell | Bladder Cancer

Germany
Universitätsklinikum Hamburg-Eppendorf
Prostate Center North West Department of Urology and Pediatric Urology

Completed

Lung Function After Robot-assisted Radical Prostate Ectomy

Lung Function

Germany
Sindh Institute of Urology and Transplantation

Completed

Effects of Intrathecal Dexmedetomidine as an Adjuvant to Low Dose Hyperbaric 0.5% Bupivacaine

Post Operative Pain

Pakistan
Armed Forces Institute of Urology, Rawalpindi

Completed

COMPARISON OF SILODOSIN AND TAMSULOSIN IN MEDICAL EXPULSIVE THERAPY OF DISTAL URETERIC CALCULI

Silodosin, Tamsulosin, Medical Expulsive Therapy, Distal Ureteric Calculi

Pakistan
BE Technologies Inc
Urology of Virginia

Completed

BE Technologies Mobile Uroflowmetry Validation Study

Overactive Bladder | Lower Urinary Tract Symptoms | Urinary Incontinence, Urge | Overactive Bladder Syndrome | BPH | Urinary Obstruction | BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms | BPH Without Urinary Obstruction | BPH Without Urinary Obstruction With Other Lower Urinary...

United States
European Association of Urology Research Foundation

Completed

Epidemiology and Outcomes of Gram Negative Urosepsis (SERPENS)

Urosepsis

Norway, Hungary, Italy, North Macedonia, Poland, Portugal, Turkey

Clinical Trials Sponsored by Urologix

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations